Germany has a long-standing reputation for life science innovation. However, most pharmaceutical and biotech companies are now headquartered in the US, and significantly more digital health solutions are developed in Silicon Valley and Boston than in Berlin or Munich..
GALS is part of a broader initiative of the German government to foster high-tech innovation and life science entrepreneurship in Germany. Now, these 4 start-up biotechs will be nurtured over the next 12 months, to push their business ideas to success, from from treating tinnitus patients with filtered music and preventing stroke via a mobile ECG app.
